217 related articles for article (PubMed ID: 6830658)
1. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
[TBL] [Abstract][Full Text] [Related]
2. Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
Verma SP; Silke B; Reynolds GW; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1992 Jan; 19(1):24-33. PubMed ID: 1375684
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
[TBL] [Abstract][Full Text] [Related]
4. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
[TBL] [Abstract][Full Text] [Related]
5. Problems in assessment of new pharmacologic agents for the heart failure patient.
Rude RE; Grossman W; Colucci WS; Benotti JR; Carabello BA; Wynne J; Malacoff R; Braunwald E
Am Heart J; 1981 Sep; 102(3 Pt 2):584-90. PubMed ID: 7270403
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
[TBL] [Abstract][Full Text] [Related]
7. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
Stephens JD; Banim SO; Spurrell RA
Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic advantages of a combined inotropic/venodilator regimen over inotropic monotherapy in acute heart failure.
Verma SP; Silke B; Nelson GI; Hussain M; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1985; 7(5):943-7. PubMed ID: 2413305
[TBL] [Abstract][Full Text] [Related]
10. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Alousi AA; Canter JM; Fort DJ
Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
[TBL] [Abstract][Full Text] [Related]
11. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
Robinson PJ; Lvoff R; Chong B; Barrett PA
Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Massie BM; Kramer B; Shen E; Haughom F
Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
Bottorff MB; Rutledge DR; Pieper JA
Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
[TBL] [Abstract][Full Text] [Related]
15. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM
Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862
[TBL] [Abstract][Full Text] [Related]
17. Intravenous use of amrinone for the treatment of the failing heart.
Mancini D; LeJemtel T; Sonnenblick E
Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic dose-response effects of intravenous amrinone in left ventricular failure complicating acute myocardial infarction.
Verma SP; Silke B; Reynolds GW; Hafizullah M; Jackson NC; Taylor SH
J Cardiovasc Pharmacol; 1985; 7(6):1101-6. PubMed ID: 2418295
[TBL] [Abstract][Full Text] [Related]
20. Vasodilator therapy for chronic left ventricular failure.
Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
